Traditionally, macroscopic and microscopic methods have been used as routine approaches for the identification
Chinese Materia Medica (CMM). By examining the morphological and tissue characteristics of CMM, they can be
identified unequivocally. In recent years, there has been a growing interest in the development of DNA-based
methods as a complementary approach, especially for discrimination of closely related species. DNA-based testing
methods and technical guidance have been published by international authorities such as The Pharmacopoeia of the
People’s Republic of China, U.S. Pharmacopeia and British Pharmacopoeia.
This research project
aims at developing DNA-based testing methods for the identification of animal-derived CMM - Cornu Cervi
Pantotrichum. This project is divided into two parts.
In the second part, DNA barcoding testing method for identification of animal-derived CMM and quality control system were developed and validated in accordance with the requirements of the Hong Kong Laboratory Accreditation Program. The generation of reference DNA barcode sequences of Cornu Cervi Pantotrichum, i.e. C. nippon and C. elaphus was completed in order to provide more comprehensive reference data for identification.
We hope that the developed DNA-based testing methods and quality control system can complement the current testing methods for identification of Cornu Cervi Pantotrichum, which help CM sectors to distinguish unscrupulous suppliers and avoid buying and selling of problematic products, protect their brand images and interests, and effectively solve the difficulties encountered by CM sectors in discriminating the authenticity of the products.